Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
GI Innovation, Inc.
AstraZeneca
Atavistik Bio, Inc
Seagen Inc.
Mayo Clinic
Mayo Clinic
Alterome Therapeutics, Inc.
Bayer
Neonc Technologies, Inc.
ViroMissile, Inc.
Rutgers, The State University of New Jersey
Arcus Biosciences, Inc.
Bristol-Myers Squibb
Kaiser Permanente
AstraZeneca
AstraZeneca